The nicotinic acid receptor - a new mechanism for an old drug

被引：138

作者：

Karpe, F ^{[1
]}

Frayn, KN ^{[1
]}

机构：

[1] Univ Oxford, Churchill Hosp, Nuffield Dept Clin Med, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England

来源：

关键词：

D O I：

10.1016/S0140-6736(04)16359-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1892 / 1894

页数：3

共 27 条

[1] [Anonymous], 1975, JAMA-J AM MED ASSOC, V231, P360
[2] Interaction between specific fatty acids, GLP-1 and insulin secretion in humans
Beysen, C
Karpe, F
Fielding, BA
Clark, A
Levy, JC
Frayn, KN
[J]. DIABETOLOGIA, 2002, 45 (11) : 1533 - 1541
[3] 15 YEAR MORTALITY IN CORONARY DRUG PROJECT PATIENTS - LONG-TERM BENEFIT WITH NIACIN
CANNER, PL
BERGE, KG
WENGER, NK
STAMLER, J
FRIEDMAN, L
PRINEAS, RJ
FRIEDEWALD, W
[J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 8 (06) : 1245 - 1255
[4] CARLSON LA, 1962, ACTA MED SCAND, V172, P641
[5] CARLSON LA, 1988, ACTA MED SCAND, V223, P405
[6] INITIAL DISTRIBUTION IN MICE OF H-3-LABELED NICOTINIC ACID STUDIED WITH AUTORADIOGRAPHY
CARLSON, LA
HANNGREN, A
[J]. LIFE SCIENCES, 1964, 3 (08) : 867 - 871
[7] The role of non-esterified fatty acids in the deterioration of glucose tolerance in Caucasian subjects: results of the Paris Prospective Study
Charles, MA
Eschwege, E
Thibult, N
Claude, JR
Warnet, JM
Rosselin, GE
Girard, J
Balkau, B
[J]. DIABETOLOGIA, 1997, 40 (09) : 1101 - 1106
[8] DAVOREN PM, 1995, DIABETES NUTR METAB, V8, P17
[9] Frayn KN, 2003, BIOCHEM SOC T, V31, P1115, DOI 10.1042/BST0311115
[10] METABOLIC EFFECTS OF SUPPRESSION OF NONESTERIFIED FATTY-ACID LEVELS WITH ACIPIMOX IN OBESE NIDDM SUBJECTS
FULCHER, GR
WALKER, M
CATALANO, C
AGIUS, L
ALBERTI, KGMM
[J]. DIABETES, 1992, 41 (11) : 1400 - 1408